Medical Device News Magazine

Hubly Surgical Receives 510k Clearance from FDA to Market Innovative Cranial Access Drill for Neurosurgical Safety in the ICU

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Hubly Surgical announced today that they received 510k clearance from the FDA to market the Hubly Drill, an innovative medical technology developed with the goal of making burr hole procedures safer and more efficient in any setting, including outside of the operating room.

A burr hole procedure is the prerequisite brain surgery for any time a physician needs to access the brain. This is done for patients with traumatic brain injury, hydrocephalus, ruptured aneurysm, stroke, subdural hematoma, epilepsy, Parkinson’s, and brain cancer and tumors. These procedures are frequently performed outside of the operating room in emergencies, yet the current bedside procedure relies on an inaccurate device, deficient in safety and efficiency features.

“Burr holes are one of the most common neurosurgical procedures we perform,” said Dr. Matthew Potts, a Cerebrovascular Neurosurgeon and Assistant Professor at Northwestern. “And at the bedside, they are often done using a cumbersome hand-cranked drill. I know first-hand how antiquated this solution is and how dangerous this procedure can be. I’m excited that Hubly has developed an improved intracranial drill for burr-hole placement.”

The Hubly Drill aims to mitigate the challenges of bedside cranial access by being the first and only cordless single-use cranial drill with advanced features for safety and efficiency in any setting. “Essentially we are bringing the precision of the operating room, which physicians are accustomed to, to the bedside,” said Founder/CEO Casey Grage.

The technology features novel innovations for safety and efficiency, including SMART Auto-Stop with a proprietary drill bit designed to reduce over-plunge (a common problem with the current standard of care). There is also a first-of-its-kind LED Force Indicator that changes color with force, increasing user control.

Grage added, “We believe the facilities that add the Hubly Drill into their workflow will recognize significant value by reducing operating room dependence and increasing access at the bedside, thus lowering hospital costs.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”